Abstract
The prevalence of myocardial abnormalities in HIV-infected patients ranges from 25 to 75% [1]. This wide range probably reflects differences in methodology, patients’ risk factors, disease stage, and environmental factors such as drug addiction or therapeutic agents. Myocardial involvement in HIVinfected patients includes dilated cardiomyopathy, myocarditis, ischemic heart disease, and neoplastic invasion from HIV-associated malignancies (e.g., non-Hodgkin’s lymphoma or Kaposi’s sarcoma). In addition, the right ventricle can be involved as a consequence of AIDS-related pulmonary disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G and the Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS Investigators (1998) Cardiac involvement in the acquired immunodeficiency syndrome: a multicenter clinical-pathological study. AIDS Res Hum Retroviruses 14:1071–7107
D’Amati G, Di Gioia CRT, Gallo P (2001) Pathological findings of HIV-associated cardiovascular disease. Ann NY Acad Sci 946:23–45
Klatt EC (2003) Cardiovascular pathology in AIDS. Adv Cardiol 40:23–48
Aretz HT (1987) Myocarditis: the Dallas criteria. Hum Pathol 18:619–624
Barbaro G, Di Lorenzo G, Soldini M et al (1999) Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Circulation 100:933–939
Herskowitz A, Tzyy-Choou W, Willoughby SB et al (1994) Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virus. J Am Coll Cardiol 24:1025–1032
Barbaro G, Barbarini G, Pellicelli AM (2001) HIV-associated coronary arteritis in a patient with fatal myocardial infarction. N Engl J Med 344:1799–1800
Twu C, Liu QN, Popik W et al (2002) Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion and death receptor-controlled pathways. Proc Natl Acad Sci USA 99:14386–14391
Barbaro G, Klatt EC (2003) Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patients. Curr Pharm Des 9:1475–1481
Holmberg SD, Moorman AC, Williamson JM et al (2002) Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet 360:1747–1748
Barbaro G, Di Lorenzo G, Cirelli A et al (2003) An open-label, prospective, observational study of the incidence of coronary artery disease in patients with HIV receiving highly active antiretroviral therapy. Clin Ther 25:2405–2418
Friis-Moller N, Weber R, Reiss P et al (2003) Cardiovascular risk factors in HIV patients: association with antiretroviral therapy. Results from DAD study. AIDS 17:1179–1193
Bozzette SA, Ake CF, Tam HK et al (2003) Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 348:702–710
The Data Collection on Adverse Events of AntiHIV Drugs (DAD) Study Group (2003). Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 349:1993–2003
Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G and the Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS investigators (1998) Cardiac involvement in the acquired immunodeficiency syndrome: a multicenter clinical-pathological study. AIDS Res Hum Retroviruses 14:1071–1077
Duong M, Dubois C, Buisson M et al (1997) NonHodgkin’s lymphoma of the heart in patients infected with human immunodeficiency virus. Clin Cardiol 20:497–502
Sanna P, Bertoni F, Zucca E et al (1998) Cardiac involvement in HIV-related non-Hodgkin’s lymphoma: a case report and short review of the literature. Ann Hematol 77:75–78
Dal Maso L, Serraino D, Franceschi S (2001) Epidemiology of HIV-associated malignancies. Cancer Treat Res 104:1–18
Heidenreich PA, Eisenberg MJ, Kee LL et al (1995) Pericardial effusion in AIDS: incidence and survival. Circulation 92:3229–3234
Pugliese A, Isnardi D, Saini A et al (2000) Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect 40:282–284
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Italia
About this chapter
Cite this chapter
Barbaro, G. (2009). Pathology of Cardiac Complications in HIV Infection. In: Barbaro, G., Boccara, F. (eds) Cardiovascular Disease in AIDS. Springer, Milano. https://doi.org/10.1007/978-88-470-0761-1_4
Download citation
DOI: https://doi.org/10.1007/978-88-470-0761-1_4
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0760-4
Online ISBN: 978-88-470-0761-1
eBook Packages: MedicineMedicine (R0)